# Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

> **NCT04199715** · PHASE1 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Heplisav-B

## Key facts

- **NCT ID:** NCT04199715
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-03
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-01-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199715, "Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04199715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*